GYG1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.009200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.435000E-01
Normal-vs-Stage2
6.337800E-01
Normal-vs-Stage3
1.739970E-01
Normal-vs-Stage4
5.656600E-01
Stage1-vs-Stage2
2.706400E-01
Stage1-vs-Stage3
2.098600E-01
Stage1-vs-Stage4
2.746000E-01
Stage2-vs-Stage3
1.101390E-01
Stage2-vs-Stage4
9.739600E-01
Stage3-vs-Stage4
2.428400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.387200E-01
Normal-vs-AfricanAmerican
6.375800E-01
Normal-vs-Asian
5.083400E-01
Caucasian-vs-AfricanAmerican
6.889400E-01
Caucasian-vs-Asian
3.391000E-01
AfricanAmerican-vs-Asian
7.436600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.120000E-01
Normal-vs-Female
8.982200E-01
Male-vs-Female
9.491600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.826200E-01
Normal-vs-Age(41-60Yrs)
9.102200E-01
Normal-vs-Age(61-80Yrs)
8.361200E-01
Normal-vs-Age(81-100Yrs)
4.350400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.727400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.575400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.384200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.311800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.261400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.159400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.747840E-01
Normal-vs-Daily Drinker
2.821200E-01
Normal-vs-Weekly Drinker
6.286200E-01
Normal-vs-Occasional Drinker
8.200800E-01
Normal-vs-Social Drinker
8.256200E-01
Non Drinker-vs-Daily Drinker
6.529600E-01
Non Drinker-vs-Weekly Drinker
3.037200E-01
Non Drinker-vs-Occasional Drinker
7.178200E-02
Non Drinker-vs-Social Drinker
7.678100E-02
Daily Drinker-vs-Weekly Drinker
5.325400E-01
Daily Drinker-vs-Occasional Drinker
1.931440E-01
Daily Drinker-vs-Social Drinker
1.206640E-01
Weekly Drinker-vs-Occasional Drinker
6.299000E-01
Weekly Drinker-vs-Social Drinker
3.047000E-01
Occasional Drinker-vs-Social Drinker
4.453200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.095800E-01
Normal-vs-Grade 2
2.046200E-01
Normal-vs-Grade 3
1.455380E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.490000E-01
Grade 1-vs-Grade 3
2.197400E-01
Grade 1-vs-Grade 4
4.095800E-01
Grade 2-vs-Grade 3
8.206600E-01
Grade 2-vs-Grade 4
2.046200E-01
Grade 3-vs-Grade 4
1.455380E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.556600E-01
Normal-vs-NonDiabetic
8.827200E-01
Diabetic-vs-NonDiabetic
4.976200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.231400E-01
Normal-vs-NoPancreatitis
8.420400E-01
Pancreatitis-vs-NoPancreatitis
8.660400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.562200E-01
Normal-vs-N1
6.368200E-01
N0-vs-N1
2.228200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.545000E-01
Normal-vs-TP53-NonMutant
8.152000E-01
TP53-Mutant-vs-TP53-NonMutant
2.348400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
